Enabling synthesis and biological studies of homogeneous heparan sulfate and chondroitin sulfate glyco-polypeptides and proteoglycans
实现均质硫酸乙酰肝素和硫酸软骨素糖多肽和蛋白聚糖的合成和生物学研究
基本信息
- 批准号:10387107
- 负责人:
- 金额:$ 21.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-03-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:Anti-Inflammatory AgentsBiologicalBiological ProcessCarbohydratesCell ProliferationCell surfaceChemicalsChondroitin Sulfate AChondroitin Sulfate ProteoglycanChondroitin SulfatesComplexCore ProteinDevelopmentEnzymesExtracellular MatrixGlycopeptidesGlycoproteinsGlycosaminoglycansGrantHeparitin SulfateHeterogeneityInflammationLifeLigationMalignant NeoplasmsMammalian CellMethodsMolecularOutputPeptidesPharmaceutical PreparationsPlayPolysaccharidesPropertyProteoglycanRoleSepsisStructureStructure-Activity RelationshipTimeVertebral columnbikuninchondroitin sulfate glycosaminoglycanfascinatenovel therapeuticspolypeptidetool
项目摘要
Proteoglycans (PGs) are ubiquitous on mammalian cell surfaces and in the extracellular
matrix. PGs are made up of heparan sulfate or chondroitin sulfate glycosaminoglycan chains
covalently attached to the core protein through tetrasaccharide linkers. PGs play important roles
in many biological processes. However, due to the heterogeneity of naturally existing PGs, it is
extremely challenging to purify well-defined structures to study the structure and activity
relationship. Traditionally, the biological functions of PGs are believed to be dictated by the
glycosaminoglycan chains attached. Evidence is emerging that the core protein may significantly
impact the glycan activities. During the last grant period, homogeneous heparan sulfate and
chondroitin sulfate glycopeptides have been synthesized, providing access to these complex
molecules for the first time. However, the synthesis required total over 100 chemical steps to
complete a glycopeptide with a heparan sulfate chain, which limited the synthetic output.
Furthermore, with the current synthetic strategy, some of the common structural features in PGs
are not accessible. To overcome these challenges, in this renewal application, the power of the
biosynthetic enzymes will be harnessed to greatly expand the capability for PG synthesis. In aim
1, the key enzymes will be produced to generate the tetrasaccharide linkage region with the core
peptide, and to extend the glycan chain. Automated synthesis strategy will be developed to further
expedite the synthesis. In aim 2, ligation strategies will be established to synthesize glyco poly-
peptides with multiple glycan chains. This will provide a powerful tool to extend the poly-peptide
backbone, and to probe the hypothesis that the core protein can modulate glycan activities. In
aim 3, synthesis of a chondroitin sulfate proteoglycan bikunin like glycoprotein will be completed.
Bikunin is an approved drug to treat the potentially life-threatening sepsis conditions, and its
mechanism is currently unclear. Aided by the structurally well-defined synthetic bikunin, the
molecular mechanisms of the anti-inflammatory activities of bikunin will be established,
demonstrating the power of synthesis in expanding the understanding of the interesting biological
properties of these complex molecules.
蛋白多糖(PG)广泛存在于哺乳动物细胞表面和细胞外。
矩阵。PGS由硫酸乙酰肝素或硫酸软骨素糖胺多糖链组成
通过四糖连接物共价连接到核心蛋白上。PGS扮演着重要的角色
在许多生物过程中。然而,由于自然存在的PG的异质性,它是
提纯定义明确的结构以研究结构和活性具有极大的挑战性
两性关系。传统上,前列腺素的生物学功能被认为是由
附着的糖胺多糖链。越来越多的证据表明,核心蛋白可能显著
影响多聚糖的活性。在最后一次拨款期间,均相硫酸乙酰肝素和
硫酸软骨素糖肽已被合成,为这些复合体提供了途径
第一次发现了分子。然而,合成总共需要100多个化学步骤来
用硫酸乙酰肝素链来完成糖肽,这限制了合成产量。
此外,在目前的合成策略下,PG中的一些常见结构特征
是无法访问的。为了克服这些挑战,在这次续订申请中,
生物合成酶将被用来极大地扩展PG合成的能力。在AIM
1,将产生关键酶,以产生与核心的四糖连接区
多肽,并延长糖链。将开发自动合成策略,以进一步
加快合成速度。在目标2中,将建立连接策略来合成糖聚糖-
具有多个糖链的多肽。这将为扩展多肽提供一个强有力的工具
并探索核心蛋白可以调节糖链活性的假设。在……里面
目的3、完成硫酸软骨素蛋白多糖Bikunin样糖蛋白的合成。
比库宁是一种被批准用于治疗潜在威胁生命的脓毒症的药物,其
机制目前尚不清楚。在结构上定义明确的合成Bikunin的帮助下,
比库宁抗炎作用的分子机制将被建立,
展示合成在扩大对有趣的生物学的理解方面的力量
这些复杂分子的性质。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Xuefei Huang其他文献
Xuefei Huang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Xuefei Huang', 18)}}的其他基金
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
- 批准号:
10432065 - 财政年份:2019
- 资助金额:
$ 21.22万 - 项目类别:
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
- 批准号:
9978709 - 财政年份:2019
- 资助金额:
$ 21.22万 - 项目类别:
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
- 批准号:
10201474 - 财政年份:2019
- 资助金额:
$ 21.22万 - 项目类别:
Synthetic glycan conjugates with bacteriophage Qbeta for broad spectrum anti-salmonella vaccines
用于广谱抗沙门氏菌疫苗的合成聚糖与噬菌体 Qbeta 缀合物
- 批准号:
10653943 - 财政年份:2019
- 资助金额:
$ 21.22万 - 项目类别:
Engineering bacteriophage Qβ conjugates with tumor associated carbohydrate antigens as multi-component anti-cancer vaccines
工程噬菌体 Qβ 与肿瘤相关碳水化合物抗原缀合物作为多组分抗癌疫苗
- 批准号:
9473167 - 财政年份:2018
- 资助金额:
$ 21.22万 - 项目类别:
Stereoselective Assembly of Challenging Glycosidic Linkages with Earth-Abundant Metal Catalysts
用地球上丰富的金属催化剂立体选择性组装具有挑战性的糖苷键
- 批准号:
9546030 - 财政年份:2018
- 资助金额:
$ 21.22万 - 项目类别:
Engineering bacteriophage Qβ conjugates with tumor associated carbohydrate antigens as multi-component anti-cancer vaccines
工程噬菌体 Qβ 与肿瘤相关碳水化合物抗原缀合物作为多组分抗癌疫苗
- 批准号:
10358502 - 财政年份:2018
- 资助金额:
$ 21.22万 - 项目类别:
Stereoselective Assembly of Challenging Glycosidic Linkages with Earth-Abundant Metal Catalysts
用地球上丰富的金属催化剂立体选择性组装具有挑战性的糖苷键
- 批准号:
10173059 - 财政年份:2018
- 资助金额:
$ 21.22万 - 项目类别:
Engineering bacteriophage Qβ conjugates with tumor associated carbohydrate antigens as multi-component anti-cancer vaccines
工程噬菌体 Qβ 与肿瘤相关碳水化合物抗原缀合物作为多组分抗癌疫苗
- 批准号:
10540343 - 财政年份:2018
- 资助金额:
$ 21.22万 - 项目类别:
Virus like particles as carriers for carbohydrate based anti-Salmonella vaccines
病毒样颗粒作为碳水化合物抗沙门氏菌疫苗的载体
- 批准号:
9118056 - 财政年份:2015
- 资助金额:
$ 21.22万 - 项目类别:
相似海外基金
Nitrous Oxide Management in a Novel Biological Process
新型生物过程中的一氧化二氮管理
- 批准号:
2789227 - 财政年份:2023
- 资助金额:
$ 21.22万 - 项目类别:
Studentship
Dynamic regulation of RNA modification and biological process
RNA修饰和生物过程的动态调控
- 批准号:
18H05272 - 财政年份:2018
- 资助金额:
$ 21.22万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2017
- 资助金额:
$ 21.22万 - 项目类别:
Discovery Grants Program - Individual
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2016
- 资助金额:
$ 21.22万 - 项目类别:
Discovery Grants Program - Individual
Organizing the Waterloo Biofilter biological process for treating wastewater concentrated by extreme water conservation plumbing
组织滑铁卢生物过滤器生物工艺处理通过极端节水管道浓缩的废水
- 批准号:
479764-2015 - 财政年份:2015
- 资助金额:
$ 21.22万 - 项目类别:
Engage Grants Program
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2015
- 资助金额:
$ 21.22万 - 项目类别:
Discovery Grants Program - Individual
Development of Biological Process for VOC treatment
VOC处理生物工艺的开发
- 批准号:
476672-2014 - 财政年份:2015
- 资助金额:
$ 21.22万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2014
- 资助金额:
$ 21.22万 - 项目类别:
Discovery Grants Program - Individual
Optimization of a biological process treating winery wastewater: anaerobic digestion integrated with Waterloo biofilter
处理酿酒厂废水的生物工艺优化:厌氧消化与滑铁卢生物过滤器集成
- 批准号:
463193-2014 - 财政年份:2014
- 资助金额:
$ 21.22万 - 项目类别:
Engage Grants Program
Micro-Scale Biological Process Automation: Modelling, Sensing and Control
微尺度生物过程自动化:建模、传感和控制
- 批准号:
42116-2013 - 财政年份:2013
- 资助金额:
$ 21.22万 - 项目类别:
Discovery Grants Program - Individual